On the public citation graph
Methylation-Based Therapies for Colorectal Cancer
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
1 of the 200 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1128/mcb.25.11.4727-4741.2005 (notice 2022-04-12).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cncr.24394openalex-snapshotThe presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history
inferredcites →https://doi.org/10.1002/cncr.28802openalex-snapshotPostoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer
inferredcites →https://doi.org/10.1002/cncr.31309openalex-snapshotA phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer
inferredcites →https://doi.org/10.1002/gcc.22529openalex-snapshotNKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy
inferredcites →https://doi.org/10.1002/hep.22110openalex-snapshotAberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/ijc.28619openalex-snapshotKRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer
inferredcites →https://doi.org/10.1007/s00432-015-1972-8openalex-snapshotHypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer
inferredcites →https://doi.org/10.1007/s13402-013-0148-2openalex-snapshotRegulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study
inferredcites →https://doi.org/10.1016/j.jcmgh.2019.04.002openalex-snapshotIntegrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas
inferredcites →https://doi.org/10.1016/s0021-9258(19)38605-3openalex-snapshotAltered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels.
inferredcites →https://doi.org/10.1016/s1470-2045(17)30422-9openalex-snapshotNivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
inferredcites →https://doi.org/10.1038/30764openalex-snapshotTranscriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
inferredcites →https://doi.org/10.1038/bjc.2014.540openalex-snapshotInterleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3
inferredcites →https://doi.org/10.1038/ncomms13177openalex-snapshot5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients
inferredcites →https://doi.org/10.1038/ng.298openalex-snapshotThe human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
inferredcites →https://doi.org/10.1038/ng1834openalex-snapshotCpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
inferredcites →https://doi.org/10.1038/ng1866openalex-snapshotHeritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
inferredcites →https://doi.org/10.1038/ng1950openalex-snapshotPolycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
inferredcites →https://doi.org/10.1038/ng1972openalex-snapshotA stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
inferredcites →https://doi.org/10.1038/nm.3174openalex-snapshotPoor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
inferredcites →https://doi.org/10.1038/sj.onc.1209154openalex-snapshotFunctional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
inferredcites →https://doi.org/10.1073/pnas.91.25.11797openalex-snapshotToxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.
inferredcites →https://doi.org/10.1089/gtmb.2016.0162openalex-snapshotWNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy
inferredcites →https://doi.org/10.1093/annonc/mdx175openalex-snapshotPrognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
inferredcites →https://doi.org/10.1093/annonc/mdx738openalex-snapshotPan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
inferredcites →https://doi.org/10.1093/annonc/mdy197openalex-snapshotTemozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation
inferredcites →https://doi.org/10.1093/annonc/mdy410openalex-snapshotThe prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial
inferredcites →https://doi.org/10.1093/annonc/mdz387openalex-snapshotConsensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
inferredcites →https://doi.org/10.1093/carcin/bgs214openalex-snapshotIL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer
inferredcites →https://doi.org/10.1093/jnci/djr153openalex-snapshotDNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
inferredcites →https://doi.org/10.1093/jnci/djv438openalex-snapshotEfficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
inferredcites →https://doi.org/10.1097/sla.0000000000002901openalex-snapshotCirculating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis
inferredcites →https://doi.org/10.1111/j.1349-7006.2010.01776.xopenalex-snapshotLong interspersed nuclear element‐1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype‐negative colorectal cancer
inferredcites →https://doi.org/10.1128/mcb.25.11.4727-4741.2005openalex-snapshotRETRACTED ARTICLE: 5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal
inferredcites →https://doi.org/10.1136/esmoopen-2018-000464openalex-snapshotPhase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases
inferredcites →https://doi.org/10.1158/1078-0432.ccr-05-0722openalex-snapshotFood and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-3518openalex-snapshotPromoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-0332openalex-snapshotMismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
inferredcites →https://doi.org/10.1158/1535-7163.mct-12-0710openalex-snapshotA Phase II Study of Temozolomide in Patients with Advanced Aerodigestive Tract and Colorectal Cancers and Methylation of theO6-Methylguanine-DNA Methyltransferase Promoter
inferredcites →https://doi.org/10.1200/jco.18.02258openalex-snapshotImpact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)
inferredcites →https://doi.org/10.1200/jco.2020.38.4_suppl.173openalex-snapshotBiomarker analysis for UPCI 14-118: Phase II study of pembrolizumab in combination with azacitidine in patients with refractory metastatic colorectal cancer.
inferredcites →https://doi.org/10.12659/msm.903927openalex-snapshotPromoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy
inferredcites →https://doi.org/10.14694/edbook_am.2014.34.91openalex-snapshotThe Evolution of Our Molecular Understanding of Colorectal Cancer: What We Are Doing Now, What the Future Holds, and How Tumor Profiling Is Just the Beginning
inferredcites →https://doi.org/10.1593/tlo.13118openalex-snapshotCirculating Methylated Septin 9 Nucleic Acid in the Plasma of Patients with Gastrointestinal Cancer in the Stomach and Colon
inferredcites →https://doi.org/10.18632/oncotarget.24617openalex-snapshotConsensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
inferredcites →https://doi.org/10.2147/cmar.s183093openalex-snapshotSequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4964507openalex-extractedDNA Methylation-Driven Biomarkers and Gene Regulatory Networks Identified in Colorectal Cancer for Improved Diagnosis and Treatment
inferred← citeshttps://doi.org/10.1007/s10528-025-11307-9openalex-snapshotTranscription Activation of DEPDC1B Upon EBF1 Loss Contributes to Cell Cycle Progression and Epithelial-Mesenchymal Transition in Colon Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.gene.2023.147887openalex-snapshotDNMT1-mediated NR3C1 DNA methylation enables transcription activation of connexin40 and augments angiogenesis during colorectal cancer progression
inferred← citeshttps://doi.org/10.1016/j.phymed.2021.153885openalex-snapshotThe phytochemical brazilin suppress DNMT1 expression by recruiting p53 to its promoter resulting in the epigenetic restoration of p21 in MCF7cells
inferred← citeshttps://doi.org/10.1111/bph.17455openalex-snapshotEpigenPlot: An interactive web platform for DNA methylation‐based biomarker and drug target discovery in colorectal cancer
inferred← citeshttps://doi.org/10.1134/s1022795424700959openalex-snapshotHypermethylation of Long Noncoding RNA Genes GAS5, HOTAIR, HOTAIRM1, and SSTR5-AS1 as Factors in the Development and Progression of Metastatic Breast Cancer
inferred← citeshttps://doi.org/10.1186/s13072-025-00646-xopenalex-snapshotGain of function p53 mutant R273H confers distinct methylation profiles and consequent YAP/TAZ signaling mediated activation of partial or full EMT states to colon tumours
inferred← citeshttps://doi.org/10.2174/1566524022666220511123104openalex-snapshotAssimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential
inferred← citeshttps://doi.org/10.2399/ana.21.852318openalex-snapshotIn silico transcriptomic analysis of ascending colon cancer unearths known and novel genes and gene sets regard to characteristic features of colon cancer
inferred← citeshttps://doi.org/10.31857/s0016675824100096openalex-snapshotHypermethylation of Long Non-Coding RNA Genes GAS5, Hotair, Hotairm1 and SSTR5-AS1 As Factors in the Development and Progression of Metastatic Breast Cancer
inferred← citeshttps://doi.org/10.3389/fmolb.2026.1922606openalex-snapshotDevelopment of an application for colorectal cancer prediction using SDC2 and TFPI2 methylation: an opportunity for early and noninvasive diagnosis in Latin-America
inferred← citeshttps://doi.org/10.3390/biomedicines11071987openalex-snapshotDNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.3390/ijms21155255openalex-snapshotDistant Metastasis in Colorectal Cancer Patients—Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review
inferred← citeshttps://doi.org/10.3390/ijms231810225openalex-snapshotSignificance of Hypermethylation of Tumor-Suppressor Genes PTGER4 and ZNF43 at CpG Sites in the Prognosis of Colorectal Cancer
inferred← citeshttps://doi.org/10.3892/mi.2024.149openalex-snapshotChemoprophylaxis of precancerous lesions in patients who are at a high risk of developing colorectal cancer (Review)
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.